Sling Therapeutics Presents Data Demonstrating Linsitinib Prevents Thyroid Eye Disease Progression in a Mouse Model at ENDO 2023 ...Middle East

News by : (PR Newswire) -
- Treatment with linsitinib in a clinically relevant mouse model demonstrated a significant reduction in autoimmune response and classical Thyroid Eye Disease (TED) symptoms, independent of TED severity - - Ongoing global Phase 2b LIDS clinical trial evaluating linsitinib for treatment of...

Hence then, the article about sling therapeutics presents data demonstrating linsitinib prevents thyroid eye disease progression in a mouse model at endo 2023 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sling Therapeutics Presents Data Demonstrating Linsitinib Prevents Thyroid Eye Disease Progression in a Mouse Model at ENDO 2023 )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار